Select year

2024 2023 2022 2021 2020 Earlier

shown/page

10

2017.06.22

CHIPSCREEN BIOSCIENCES was invited to participate in 2017 China International Drug Information Conference and 9th DIA China Annual Meeting
CHIPSCREEN BIOSCIENCES was invited to participate in 2017 China International Drug Information Conference and 9th DIA China Annual Meeting

2017.05.19

Dr. Lu Xianping was invited to attend 2017 PKU diabetes forum
Dr. Lu Xianping was invited to attend 2017 PKU diabetes forum

2017.04.17

Phase III clinical trial of breast cancer approved by Taiwan TFDA in Chidamide
Phase III clinical trial of breast cancer approved by Taiwan TFDA in Chidamide

2017.03.30

Experts from World Health Organization visit CHIPSCREEN BIOSCIENCES
Experts from World Health Organization visit CHIPSCREEN BIOSCIENCES

2017.03.27

Dr. Lu Xianping was invited to attend 2017 Asia Pacific Drug Research and Development Leader Summit
Dr. Lu Xianping was invited to attend 2017 Asia Pacific Drug Research and Development Leader Summit

2017.03.13

Chidamide won the most clinically valuable innovative medicine of the second China Pharmaceutical Innovative Brand in 2016
Chidamide won the most clinically valuable innovative medicine of the second China Pharmaceutical Innovative Brand in 2016

2017.01.05

Our company has won the national titles of " high-tech enterprise" and " Shenzhen high-tech enterprise"
Our company has won the national titles of " high-tech enterprise" and " Shenzhen high-tech enterprise"

2016.12.27

As a representative of Pingshan's innovation drive, our company was reported by Guangming net and other media
As a representative of Pingshan's innovation drive, our company was reported by Guangming net and other media

2016.11.29

Phase III clinical trial of Chiglitazar, a new CHIPSCREEN BIOSCIENCES anti-type 2 diabetes drug, completed
Phase III clinical trial of Chiglitazar, a new CHIPSCREEN BIOSCIENCES anti-type 2 diabetes drug, completed

2016.11.29

The second HDACi ( histone deacetylase inhibitor ) summit was successfully held in Chengdu
The second HDACi ( histone deacetylase inhibitor ) summit was successfully held in Chengdu

Media contact

Media contact

（+86）0755-36993500
pr@chipscreen.com